Skip to main content
. Author manuscript; available in PMC: 2016 Dec 12.
Published in final edited form as: Int J Tuberc Lung Dis. 2013 Aug;17(8):1023–1028. doi: 10.5588/ijtld.13.0061

Table 1.

Demographic and clinical variables associated with positive stool culture compared to other TB in sites other than stool*

Variable Positive stool culture (n = 101)
n (%)
TB in sites other than stool (n = 127)
n (%)
P value
Age, years, median [IQR] 29 [26–37] 32 [28–40] 0.04
Male sex 73 (72) 78 (61) 0.08
Country of evaluation
 Cambodia 40 (40) 58 (46)
 Thailand 10 (10) 22 (17)
 Viet Nam 51 (51) 47 (37) 0.08
Persons hospitalised 9 (9) 5 (4) 0.12
Symptoms
 Cough 74 (73) 94 (74) 0.90
 Fever 74 (73) 87 (69) 0.43
 Diarrhoea 32 (32) 44 (35) 0.64
 Nausea or vomiting 32 (32) 50 (39) 0.23
 Abdominal pain 44 (43) 53 (42) 0.78
 Night sweats 42 (41) 60 (47) 0.39
 Difficulty breathing 61 (60) 61 (48) 0.06
 Chest pain 49 (49) 64 (50) 0.78
 Weight loss 79 (78) 86 (68) 0.08
 Fatigue 78 (77) 94 (74) 0.58
 Chills 48 (47) 63 (50) 0.75
BMI, kg/m2, median [IQR] 18 [17–20] 19 [17–21] 0.05
Enlarged lymph nodes 33 (33) (n =100) 35 (28) 0.37
Performance status: Karnofsky score ≥90§ 49 (49) 76 (60) 0.09
Chest radiograph with any abnormality 71 (72) (n = 99) 73 (61) (n = 120) 0.09
 Cavity 13 (13) 11 (9) 0.30
Pulmonary TB 91 (90) 115 (91) 0.91
Sputum bacillary burden (n = 91) (n = 115)
 Minimal (smear-negative) 31 (34) 81 (70)
 Moderate (1+) 30 (33) 23 (20)
 Most (2–3+) 30 (33) 11 (10) <0.001
Extra-pulmonary TB 42 (42) 33 (27) (n = 122) 0.02
CD4 count, cells/μl, median [IQR] 75 [20–213] 139 [47–281] 0.004
*

If n is not specified for the row, column totals apply.

Pearson’s χ2 or Wilcoxon rank sum.

P < 0.05.

§

Karnofsky score measures the extent of impairment (performance status) secondary to illness.

TB = tuberculosis; IQR = interquartile range; BMI = body mass index.